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Dietary protein restriction in isolated glomeruli from rats with bilateral
ureteral obstruction. Dietary protein restriction ameliorates the de-
crease in GFR and renal plasma flow that occurs 24 hours after the
onset of bilateral ureteral obstruction (BUO). The vasoactive hor-
mones, prostaglandins (PGs) and thromboxane (Tx), have a role in the
changes in renal function described above. Thus, we evaluated the
effect of dietary protein restriction on the production of PGE2, 6-keto
PGF1, and TxB2 and on the activities of cyclooxygenase and phospho-
lipases A2 and C in glomeruli isolated from sham-operated control
(SOC) and BUO rats fed a low (6% casein) or a normal protein (23%
casein) diet for approximately four weeks. A normal protein diet
compared to a low protein diet significantly increased the glomerular
production of PGE2, 6-keto PGF1,, and Tx82 in SOC rats. Glomeruli of
rats with BUO fed a normal protein diet had further increased produc-
tion of eicosanoids when compared to glomeruli of SOC rats ingesting
the same diet. The production rates of eicosanoids correlated well with
the activity of cyclooxygenase in the two groups of rats. On the other
hand, a low protein diet completely abolished the increase in glomerular
eicosanoid production seen in rats with BUO. The synthetic levels of
eicosanoids were comparable in low protein-fed SOC and BUO rats,
indicating normalization of glomerular eicosanoid production in BUO
rats fed a low protein diet. Moreover, there were no significant
differences in the activities of cyclooxygenase and phospholipases A2
and C between the SOC and BUO rats. We demonstrated previously
that increases in the activities of cyclooxygenase and phospholipase A2
have a key role in glomerular eicosanoid production in rats with BUO.
Thus, our results indicate that dietary protein restriction prevents the
increase in production of eicosanoids by glomeruli due to inactivation of
phospholipase A2 and cyclooxygenase in the setting of BUO of 24 hours
duration. The protective effect of dietary protein restriction on renal
function in rats with BUO may be due in part to normalization of the
glomerular production of eicosanoids, particularly TxA2.
Prostaglandins (PGs) and thromboxane (Tx) are synthesized
from arachidonic acid released from membrane phospholipids
by the action of phospholipases (PLs) A2 and C through the
cyclooxygenase pathway [1—3]. We found previously that a diet
containing low (6% casein), normal (23% casein) or high (40%
casein) protein modified the activities of cyclooxygenase and
membranous phosphatidylethanolamine (PE)-specific PLA2
and the production of the vasodilatory PGs, PGE2 and prosta-
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cyclin (measured as the stable metabolite, 6-keto PGFIa) and
the vasoconstrictor, TxA2 (measured as the stable metabolite,
TxB2) in glomeruli obtained from rats [4]. However, there was
a concomitant decrease in the activity of phosphatidylcholine
(PC)-specific PLA2 and no change in the activity of phosphati-
dylinositol-4,5-biphosphate (PIP2)-specific PLC in glomerular
membranes of rats fed a high versus a low protein diet [4]. Don
et a! reported that increased production of eicosanoids by
glomeruli of rats fed a high protein (40% casein) diet was
decreased to levels observed in glomeruli of rats fed a low
protein (8.5% casein) diet when the rats were pretreated with
the angiotensin converting enzyme (ACE) inhibitor, enalapril
[5]. Also, bilateral ureteral obstruction (BUO) caused a signif-
icant increase in the activities of cyclooxygenase and mem-
brane-bound PE and PC-specific PLA2 together with an in-
crease in the production of PGE2, 6-keto PGFIa and TxB2 in
glomeruli of rats fed a normal protein diet [6, 7]. Prior inhibition
of the synthesis of endogenous angiotensin II with the ACE
inhibitor, enalaprilat, prevented the increase in eicosanoid
production and the increase in the activities of cyclooxygenase
and membrane-associated PE-specific PLA2 but did not inhibit
the increase in the activity of membrane-associated PC-specific
PLA2 [6, 7]. The activity of membranous PIP2-specific PLC was
decreased in the setting of BUO [7]. These observations suggest
a role of angiotensin Il-induced activation of the PE-specific
PLA2 cyclooxygenase pathway in enhanced production of
glomerular eicosanoids observed under both of the particular
conditions.
Dietary protein restriction has a beneficial effect on the
progression of acute or chronic renal disease through a decrease
in intraglomerular pressure and plasma flow [8—11]. Previous
micropuncture studies [8] demonstrated a protective effect of
dietary protein restriction on single nephron function in rats
with BUO of 24 hours duration. Rats fed a low protein (6%
casein) diet compared to rats fed a high protein (40% casein)
diet had a significantly greater single nephron glomerular filtra-
tion rate (SNGFR) and glomerular capillary plasma flow (QA)
after BUO of 24 hours duration [8]. Inhibiting the synthesis of
endogenous TxA2 with the thromboxane synthase inhibitor
OKY-1581 markedly ameliorated the fall in SNGFR and QA
observed in BUO rats fed a high protein diet but did not affect
these measurements in BUO rats fed a low protein diet [8].
These observations strongly suggest that the protective effect of
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dietary protein restriction on renal hemodynamics in the setting
of BUO is at least related to inhibition of the production and/or
the action of TxA2.
The biochemical mechanisms underlying the beneficial effect
of dietary protein restriction on renal hemodynamics in BUO
rats are not well understood. Thus, the purpose of the present
study was to evaluate directly the effect of low protein (6%
casein) feeding on the glomerular production of PGE2, 6-keto
PGF1, and TxB2 as regulators of renal hemodynamics and to
compare these results with those obtained by feeding a normal
protein (23% casein) diet to sham-operated control (SOC) rats
and rats with BUO of 24 hours duration. To examine the
biochemical basis by which low protein feeding may alter the
production rates of eicosanoids in glomeruli, we also measured
the activity and mass of cyclooxygenase and the activities of
PLs A2 and C in glomeruli obtained from low or normal
protein-fed SOC and BUO rats.
Methods
Chemicals and reagents
Arachidonic acid, L-a-PC, L-a-PE, L-a-phosphatidylserine
(PS) and goat anti-rabbit immunoglobulin G (IgG, whole mole-
cule) were purchased from Sigma (St. Louis, Missouri, USA).
Sodium iodine (125J) was obtained from Amersham (Arlington
Heights, Illinois, USA) and (arachidonyl-l-'4C)PC, (arachido-
nyl-l-'4C)PE and (inositol-2-3H)PIP2 were supplied from New
England Nuclear (Boston, Massachusetts, USA). Antisera
against cyclooxygenase 1 or cyclooxygenase 2 and the stan-
dards cyclooxygenases 1 and 2 were obtained from Cayman
Chemical Co. (Ann Arbor, Michigan, USA).
Dietary design and animal models
Female Sprague-Dawley rats (Japan Biochemical Supple-
ment Center, Tokyo, Japan) weighing approximately 200 g were
assigned to two dietary regimens. The animals were pair-fed
isocaloric diets consisting of either low amounts of protein (6%
casein) or normal amounts of protein (23% casein) for approx-
imately four weeks. The composition of the diets and the
feeding method were reported previously [4, 12]. Dietary com-
positions such as minerals, vitamin mixtures and fat were
identical except for the greater sucrose content in the 6% casein
diet [4, 121. The amount of diet given was not substantially
different between the two groups of rats and food consumption
was monitored daily during the four week period of dietary
conditioning. After the period of dietary treatment the rats were
subjected to sham operation or bilateral ureteral ligation under
light ether anesthesia as previously reported [6, 7, 131. The
operated animals were given no access to food or water and
kidneys were harvested 24 hours after surgery from each group
of rats.
Preparation of isolated glomeruli
Isolated glomeruli were prepared as previously reported [4, 6,
7, 13]. In brief, the abdominal cavity of rats was opened under
pentobarbital anesthesia (4 mg/lOU g body wt intraperitoneally)
and both kidneys were thoroughly perfused with phosphate-
buffered saline injected just above the bifurcation of the aorta.
The kidneys were immediately harvested, decapsulated and
dissected into cortices and medullas. Isolated glomeruli were
then obtained from the cortices by sieve techniques (mesh size
250, 150 and 75 tm). The preparations were confirmed to
consist of over 90% isolated glomeruli by light microscopy.
Eicosanoid production
Glomerular eicosanoid production was determined by the
protocol previously described [4, 6, 7, 13]. Isolated glomeruli
were suspended in warm Hanks' balanced salt solution (HBSS)
and preincubated at 37°C for 10 minutes. The glomeruli (ap-
proximately 100 g proteinl500 l HBSS) were transferred into
two plastic centrifuge tubes. One was immediately centrifuged
at 10,000 x g for one minute at room temperature and the
supernatant (preincubation sample) was removed. The other
was further incubated at 37°C for 10 minutes under continuous
agitation (80 cycles/mm). The incubation was then terminated
by centrifugation (10,000 x g for 1 mm) at room temperature
and the supernatant (incubation sample) was decanted. The
supernatants were stored at —80°C for the subsequent determi-
nation of PGE2, 6-keto PGFIa and TxB2. The net production of
PGE2, 6-keto PGFIa and TxB2 was determined by subtracting
the production of the eicosanoids during 10 minutes of prein-
cubation from the production of these compounds during 10
minutes of incubation.
Enzyme sources
Glomerular membranes and cytosolic extracts were prepared
as previously reported [4, 7, 13]. Isolated glomeruli were
washed twice with cold Ca and Mg-free HBSS. The
preparations were then suspended in 250 .d of ice-cold homoge-
nate buffer consisting of 25 mM Tris-HC1, pH 7.5, containing 1
mM EDTA, 1 mM dithiothreitol and 100 U/mi trazylol. Homog-
enization was performed with 20 strokes of a Teflon-glass
homogenizer and homogenates were centrifuged at 100,000 x g
for 60 minutes. The supernatants were stored at —80°C as
cytosolic extracts. The pellets were washed with 2 ml of
ice-cold homogenate buffer and collected by centrifugation at
100,000 x g for 60 minutes. The washed pellets were resus-
pended in 250 d of ice-cold homogenate buffer and stored at
—80°C as membrane extracts.
Cyclooxygenase activity
The activity of cyclooxygenase was determined from the
production rates of PGE2 by isolated glomeruli in the presence
of an excess of free arachidonic acid as previously described [4,
6, 7, 13]. Isolated glomeruli suspended in warm HBSS were
preincubated at 37°C for 10 minutes. The glomeruli (approxi-
mately 100 g protein/500 1.d HBSS) were transferred into two
plastic centrifuge tubes. One was immediately centrifuged at
10,000 x g for one minute at room temperature and the other
was further incubated at 37°C for 10 minutes with 30 tM
arachidonic acid under rocking (80 cycles/mm). After termina-
tion of the reaction by centrifugation (10,000 x g for 1 mm) the
supernatants were kept at —80°C until the PGE2 assay was
performed. The net production of PGE2 was calculated by
subtracting the production of the eicosanoid in a 10-minute
preincubation period from the production of this compound in a
10-minute incubation period. The arachidonic acid in the assay
samples, diluted to carry out the immunoassays, did not inter-
fere with the quantitation of PGE2.
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Cyclooxygenase mass
The amount of cyclooxygenase was determined by Western
blotting of glomerular membranes as previously reported [4, 7,
13]. Membranes of glomeruli were dissolved in sodium dode-
cylsulfate (SDS) sample buffer and heated at 90°C for two
minutes. The glomerular membranes (2.5 jig protein for cy-
clooxygenase 1 and 10 to 320 jig protein for cyclooxygenase 2)
were subjected to 13.5% SDS-polyacrylamide gel electrophore-
sis (SDS-PAGE) according to Laemmli [14]. The membrane
proteins were electrophoretically transferred to nitrocellulose
sheets in cold transfer buffer (20% methanol containing 25 mM
Tris and 190 mr.s glycine). The nitrocellulose sheets were then
incubated for 15 minutes with 20 mrs Tris-HC1, pH 7.5, con-
taining 3% gelatin, 500 ms NaC1 and 0.02% NaN3 to saturate
non-specific binding sites before washing three times for five
minutes each with 20 mrvt Tris-HCI, pH 7.5, containing 500 mM
NaC1 and 0.05% Tween 20 (W-buffer). The membrane proteins
on the nitrocellulose sheets were reacted for 60 minutes at room
temperature with rabbit antisera (1:1000 dilution) against cy-
clooxygenase I or cyclooxygenase 2 in immunoblotting buffer
(W-buffer containing 1% gelatin and 0.02% NaN3). After wash-
ing three times for five minutes each with W-buffer the nitro-
cellulose sheets were further incubated for 30 minutes at room
temperature with '251-labeled goat anti-rabbit antibody (4 mil-
lion cpm/ml) in immunoblotting buffer. The sheets were com-
pletely dried overnight and autoradiographed for 24 hours. The
intensity (arbitrary units) of the blots obtained from autoradiog-
raphy was determined with a GS 300 Densitometer (Hoefer
Scientific Instruments, San Francisco, California, USA). The
protein content (2.5 jig) of glomerular membranes used for the
determination of cyclooxygenase 1 was within the linear range
of detection.
Phospholipase A2 assay
PLA2 activity was determined using the protocol previously
reported [4, 7]. In brief, glomerular membranes or cytosolic
extracts (approximately 100 jig protein) suspended in 50 .d of
homogenate buffer were mixed well with 200 jd of PLA2 assay
buffer consisting of 25 msi Tris-HC1 buffer, pH 8.5, containing
5 mM CaC12. The mixture was preincubated for five minutes at
37°C under continuous rocking (100 cycles/mm). The reaction
was done for 60 minutes at 37°C under vigorous agitation (160
cycles/mm) by addition of 50 jil of the phospholipid emulsion
[50 jig PC and 0.05 jiCi (14C)PC or 50 jig PE and 0.05 jiCi
('4C)PE] suspended in PLA2 assay buffer. The reaction was
terminated by adding 2 ml of CHCI3/CH3OH/conc HCI (200:
100:0.5, vollvol). After extraction of phospholipids the dried
chloroform layer was resuspended in 100 jil of hexane/ethyl
ether/acetic acid (80:20:2, vol/vol). The silica gel G plate
spotted with the extracted phospholipids and unlabeled arachi-
donic acid as a carrier was developed in the same solvent. After
visualization with iodine vapor the lipid zone corresponding to
arachidonic acid was scraped and the radioactivity was mea-
sured with a liquid scintillation spectrophotometer. Either
glomerular membranes or cytosolic extracts boiled for 30 min-
utes were used as a tissue blank. The radioactivity of ('4C)
arachidonic acid hydrolyzed from (14C)PC or (14C)PE was
linear for 90 minutes of incubation and up to 250 jig of protein
in the preparation.
Phospholipase C assay
PLC activity was measured by monitoring the release of
[3H]inositoltriphosphate (1P3) from [3H]PIP2 using the protocol
previously reported [4, 7]. Glomerular membranes or cytosolic
extracts (approximately 100 jig protein) in 50 jil of homogenate
buffer mixed well with 200 jil of PLC assay buffer (25 mM
Tris-HC1, pH 7.4, containing 100 jiM CaCl2, 10 m'vi MgCl2 and
5 mM LiCI) were preincubated for five minutes at 37°C with
continuous shaking (100 cycles/mm). The mixture was incu-
bated for 30 minutes at 37°C under vigorous agitation (160
cycles/mm) with 50 j.d of the phospholipid emulsion [6 jig PS
and 0.005 jiCi (3H)PIP2} suspended in PLC assay buffer. The
reaction was terminated by addition of 1 ml of methanoll
chloroform (2:1, vol/vol). After further addition of 0.5 ml of
chloroform and 0.5 ml of distilled water the reaction mixture
underwent vigorous vortexing. The aqueous layer of the sample
containing released (3H)1P3 was removed and the radioactivity
was measured in a liquid scintillation spectrophotometer. Ei-
ther glomerular membranes or cytosolic extracts boiled for 30
minutes were used as a tissue blank. The radioactivity of
(3H)IP3 released from (3H)PIP2 was linear for 60 minutes of
incubation and up to 500 jig of protein in the preparation.
Determination of eicosanoids
The glomerular production of PGE2, 6-keto PGF1a and TxB2
was determined using eicosanoid immunoassay kits purchased
from Cayman Chemical Co. (Ann Arbor, Michigan, USA). The
cross reactivities of the antibody against PGE2, 6-keto PGFIa or
TxB2 have been reported previously [13].
Calculations and statistical analysis
Data reported are means SE of values obtained from six
separate glomerular preparations. The protein content of gb-
merular preparations was determined by the method of Lowry
et al [15]. Values for the production of eicosanoids and the
activities of PLs A2 and C are corrected for the protein content
of the glomerular preparations and represent per mg protein per
incubation time indicated. The mass of cyclooxygenase 1 is in
arbitrary units per 2.5 jig of gbomerular membrane protein.
Statistical analysis was performed by Student's 1-test.
Results
Effects of dietary protein restriction on body and
kidney weight
Body and kidney weight of rats was measured at the time of
sacrifice. Body (N = 6) and kidney (N = 12) weight was 248
(means) 3.8 g (SE) and 0.93 0.03 g, respectively, in low
protein-fed SOC rats and 255 3.3 g and 1.03 0.02 g,
respectively, in normal protein-fed SOC rats. Dietary protein
restriction significantly (P < 0.025) reduced kidney weight but
did not significantly affect body weight.
Glomerular eicosanoid production
Table 1 shows data on the glomerular production (pg/mg
protein/lO mm of incubation) of PGE2, 6-keto PGF1, and TxB2
in SOC (N = 6) and BUO (N = 6) rats fed a low or a normal
protein diet. The glomerular production of PGE2, 6-keto PGFIa
and TxB2 was significantly greater by 1.7, 1.8 and 2.1 times,
respectively, in SOC rats fed a normal protein diet than in those
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Table 1. Eicosanoid production by glomeruli isolated from control
rats or rats with bilateral ureteral obstruction fed a low or a normal
protein diet
pg/mg protein/lO mm
Low protein Normal protein
Soc BUO Soc BUO
PGE2
6-keto PGF1
TxB2
610 28
64 7
51 7
582 42
68 7
57 8
1062 88
116 13°106 l2
1836 169ab
194 14°"
187 17°"
Isolated glomeruli were prepared from sham-operated control (SOC)
rats and rats with bilateral ureteral obstruction (BUO) that had been fed
a low (6% casein) or a normal (23% casein) protein diet. Isolated
glomeruli were incubated in 500 1.d Hanks' balanced salt solution for 10
minutes at 37°C and eicosanoids in the supernatant buffer were deter-
mined by specific immunoassays. Data reported are means SE of
values obtained from six separate glomerular preparations of each
group of rats. Abbreviations are: PGE2, prostaglandin E2; 6-keto
PGF1a, 6-keto prostaglandin Fia; TxB2, thromboxane B2.
a P < 0.005 when comparing the soc or BUO value of normal
protein with each value of low protein
b P < 0.005 compared to the SOC value
fed a low protein diet. Glomeruli isolated from rats with BUO
fed a normal protein diet biosynthesized greater amounts of
PGE2, 6-keto PGF,, and TxB2 by 1.7, 1.7 and 1.8 times,
respectively, than glomeruli obtained from soc rats ingesting
the same diet. By contrast, no significant increase in the
glomerular production of these three eicosanoids was seen in
rats with BUO versus soc rats fed a low protein diet.
Levels of cyclooxygenase
Figure 1 shows immunoblots on the characterization of
antisera against cyclooxygenase 1 or cyclooxygenase 2. The
amounts of the standards, cyclooxygenases 1 and 2, applied
were 0.5 to 1.5 pmole for the antisera against cyclooxygenase 1
and 15 to 60 pmole for the antisera against cyclooxygenase 2.
The antisera against cyclooxygenase 1 primarily detected cy-
clooxygenase 1 (72 kDa) with 21% of the cross reactivity with
cyclooxygenase 2 (77 kDa). The antisera against cyclooxygen-
ase 2 specifically reacted with cyclooxygenase 2 with no recog-
nition of cyclooxygenase 1. The limit of detection of the
standard, cyclooxygenase 1 or cyclooxygenase 2, by the anti-
sera against cyclooxygenase I or cyclooxygenase 2 was less
than 0.5 pmole or approximately 15 pmole. The sensitivity was
over 30 times lower in the antisera against cyclooxygenase 2
than in the antisera against cyclooxygenase 1.
As shown in Figure 2, immunodetectable amounts of cy-
clooxygenase 1 (72 kDa) existed in glomerular membrane (2.5
g protein) preparations. No detection of cyclooxygenase 2 by
both of the antisera against cyclooxygenase 1 or cyclooxygen-
ase 2, however, was observed in glomerular membrane prepa-
rations (data not shown) while more amounts (10 to 320 sg
protein) of the preparations were applied for immunoblotting.
Neither cyclooxygenase I nor cyclooxygenase 2 was detected
in cytosolic extracts of glomeruli. In addition, details of the
characterization of less intense lower-molecular-weight bands
detected by the antisera against cyclooxygenase 1 were re-
ported previously [4, 7, 161.
Table 2 presents data on the relative levels of glomerular
cyclooxygenase in SOC (N = 6) and BUO (N = 6) rats fed a low
or a normal protein diet. The mass (arbitrary units) of cycloox-
ygenase 1 and the activity (pg PGE2 synthesized/mg protein/b
mm) of cyclooxygenase were significantly greater by 1.3 and 2.9
times, respectively, in SOC rats fed a normal protein diet than
in those fed a low protein diet. Glomeruli isolated from rats with
BUO ingesting a normal protein diet had significantly increased
mass of cyclooxygenase I and activity of cyclooxygenase by 1.2
and 1.9 times, respectively, when compared to glomeruli ob-
tained from SOC rats given the same diet. The mass of
cyclooxygenase 1 and the activity of cyclooxygenase, however,
were not significantly different in low protein-fed SOC and
BUO rats.
Phospholipase activities
In previous studies [4, 7] we examined in detail the substrate
preference of PLA2 for the membrane phospholipids, PC and
PE, in rat glomerular membranes and cytosolic extracts. The
PLA2 was shown to have substrate specificity for PC or PE
when we examined the hydrolysis of ('4C) arachidonic acid at
sn-2 position of radiolabeled PC or PE formed micelles with an
excess of unlabeled PC or PE [4, 7].
Table 3 shows data on the relative activities (cpm/mg protein!
incubation time indicated) of PLs A2 and C in glomeruli
obtained from low protein-fed SOC (N = 6) and BUO (N = 6)
rats. PC-specific PLA2 exhibited a greater activity in membrane
extracts than in cytosolic extracts. By contrast, the activities of
PE-specific PLA2 and PIP2-specific PLC were primarily present
in cytosolic extracts but not in membrane extracts. These
findings are consistent with those of our previous studies [4, 7].
The activities of PC-specific and PE-specific PLA2 in rats with
BUO were not significantly different from those of SOC rats.
Likewise, there was no significant difference in PIP2-specific
PLC activity between SOC and BUO rats. Dietary protein
restriction prevented not only increases in the production of
eicosanoids and the mass and activity of cyclooxygenase, but
also the changes in the activities of PLs A2 and C [7] observed
at 24 hours after the onset of BUO.
Discussion
The present study elucidates the effect of dietary protein
restriction on the glomerular production of vasodilatory pros-
taglandins, PGE2 and prostacyclin (measured as the stable
metabolite, 6-keto PGF,,) and the vasoconstrictor, TxA2 (mea-
sured as the stable metabolite, TxB2) in rats with BUO of 24
hours duration. Rats with BUO fed a normal protein (23%
casein) diet had significantly augmented glomerular production
of PGE2, 6-keto PGF1a and TxB2 by 73%, 67% and 76%,
respectively, compared to SOC rats fed the same diet. Com-
pared to rats fed a normal protein diet, rats fed a low protein
(6% casein) diet had markedly decreased glomerular production
of PGE2, 6-keto PGFJ,, and TxB2 by 43%, 45% and 52%,
respectively, in SOC and by 68%, 65% and 70%, respectively,
in BUO. Interestingly, the production of the three eicosanoids
was comparable in SOC and BUO rats fed a low protein diet.
Low protein feeding prevented an increase in eicosanoid pro-
duction by glomeruli isolated from rats with BUO, implying that
dietary protein restriction normalizes altered production of
glomerular eicosanoids as a consequence of BUO of 24 hours
duration.
To examine the biochemical mechanisms responsible for the
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Fig. 1. Western blots on the characterization
of antisera against cyclooxygenase (COX) 1
or cyclooxygenase 2. The amounts of the
standards, cyclooxygenase 1 (72 kDa) and
cyclooxygenase 2 (77 kDa), applied were 0.5
to 1.5 pmole for the antisera against
cyclooxygenase 1 (A) and 15 to 60 pmole for
the antisera against cyclooxygenase 2 (B).
Western blotting was performed as described
in Methods.
effect of low protein feeding on preventing the enhanced
production of glomerular elcosanoids in the setting of BUO, we
evaluated the activity and mass of cyclooxygenase and the
activities of PLs A2 and C in glomeruli obtained from low
protein-fed SOC and BUO rats comparing with those of gb-
meruli isolated from normal protein-fed SOC and BUO rats. In
the present study we did not determine the activities of PLs A2
and C in glomeruli obtained from SOC and BUO rats fed a
normal protein diet because we had already reported the
activities of those enzymes in a previous study [7]. Rats with
BUO fed a normal protein diet had significantly increased
activity and mass of glomerular cyclooxygenase by 87% and
24%, respectively, compared to SOC rats ingesting the same
diet, indicating that BUO enhances glomerular eicosanoid pro-
duction via an increase in the activity of cyclooxygenase related
at least in part to de novo synthesis of the enzyme.
Relative to a normal protein diet, a low protein diet caused a
marked decrement in the activity and mass of glomerular
cyclooxygenase by 66% and 25%, respectively, in SOC rats and
by 83% and 43%, respectively, in rats with BUO. In contrast to
a normal protein diet, a low protein diet prevented the increase
in activity and mass of glomerular cyclooxygenase in BUO
versus SOC rats. Moreover, low protein feeding abolished
changes in the activities of PC-specific and PE-specific PLA2
and PIP2-specific PLC observed in glomeruli isolated from rats
subjected to BUO of 24 hours duration [7]. As described in
detail above, the PE-specific PLA2 . cyclooxygenase pathway
has an important role in enhancing glomerular eicosanoid
production in the pathophysiological state of BUO [7]. Both
PC-specific PLA2 and PIP2-specific PLC are not the enzymes
responsible for the release of arachidonic acid from membrane
phospholipids at least at 24 hours after the induction of BUO
[7]. Accordingly, the results of the present study demonstrate
that dietary protein restriction prevents the increase in activity
of the PE-specific PLA2 cyclooxygenase pathway in glomeruli
of rats with BUO, causing normalization of increased produc-
tion of glomerular eicosanoids observed at 24 hours after the
onset of BUO.
Low Norma'
Protein Protein
Fig. 2. Western blots for the determination of cyclooxygenase 1 (72
kDa) mass in glomerular membranes (2.5 jsg protein) of sham-operated
control (S) rats and rats with bilateral ureteral obstruction (B)fed a low
(6% casein) or a normal (23% casein) protein diet. Western blotting was
performed as described in Methods.
It has been recently demonstrated that there are two types of
cyclooxygenase isoenzymes called cyclooxygenase I and 2
[17]. There is 75% homology between the sequence of cycloox-
ygenases 1 and 2 [17]. Cyclooxygenase 1 (constitutive enzyme)
extensively distributes to mesangial cells, tubule epithelia,
endothelial cells and interstitial cells of the kidney [17]. On the
other hand, the appreciable expression of cyclooxygenase 2
(inducible enzyme) is not seen in the kidney [17]. This enzyme
is presumably up-regulated rapidly in the situation associated
with increased cell replication or differentiation [17]. The mass
of cyclooxygenase 1 was significantly augmented with in-
creased protein intake. BUO further elevated the mass of
cyclooxygenase 1 under increased protein intake. By contrast,
kDarr 72
SB SB
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Table 2. Levels of cyclooxygenase in glomeruli isolated from control rats or rats with bilateral ureteral obstruction fed a low or a normal
protein diet
Low protein Normal protein
Soc BUO Soc BUO
Mass (COX 1) 4.07 0.35 3.85 0.41 5.42 0.33a 6.70 O38
Activity (COX) 3057 462 2848 545 8980 1015b 16763 l269'
Glomerular membrane preparations were obtained from sham-operated control (SOC) rats and rats with bilateral ureteral obstruction (BUO) fed
a low (6% casein) or a normal (23% casein) protein diet. The mass of cyclooxygenase (COX) 1 was determined by Western blotting as described
in Methods. Data reported are in arbitrary units per 2.5 g of membrane protein and represent means sa of values obtained from six separate
glomerular membrane preparations of each group of rats. The activity of cyclooxygenase was determined from the production of PGE2 by glomeruli
incubated with 30 LM arachidonic acid for 10 minutes at 37°C. Values reported are means SE of pg PGE2 synthesized/mg proteinhlo mm obtained
from six separate glomerular preparations of each group of rats.
a P < 0.025 and b P < 0.005 when comparing the soc or BUO value of normal protein with each value of low protein
P < 0.05 and CI P < 0.005 compared to the soc value
Table 3. Activities of phospholipases in glomeruli isolated from control rats or rats with bilateral ureteral obstruction fed a low protein diet
SOC BUO
M CM C
PC-specific PLA2 9137 789 4973 610° 10405 825 4323 554°
PE-specific PLA2 7809 389 32444 1767° 8188 419 31697 2831°
PIP2-speciflc PLC 2417 200 17833 1433° 2010 382 15066 856°
Glomerular preparations were prepared from sham-operated control (SOC) rats and rats with bilateral ureteral obstruction (BUO) that had been
fed a low protein (6% casein) diet. Glomerular preparations were incubated for 60 minutes at 37°C with ['4C}phosphatidylcholine (PC) or
['4C]phosphatidylethanolamine (PE) for the determination of the activity of PC-specific or PE-specific phospholipase A2 (PLA2) and for 30 minutes
at 37°C with [3H]phosphatidylinositol-4,5-biphosphate (PIP2) for the determination of the activity of PIP2-speciflc phospholipase C (PLC). The
activity of PLA2 or PLC was determined by monitoring ['4Cjarachidonic acid or [3H]inositoltriphosphate released from the radiolabeled
phospholipids and corrected for the protein content of each glomerular preparation. Data reported are means SE of values obtained from six
separate glomerular preparations of the two groups of rats and represent cpm/mg protein/incubation time performed. Abbreviations are: M,
membrane; C, cytosol.
a P < 0.005 compared to the membrane value
no expression of cyclooxygenase 2 was recognized in the SOC
and BUO setting fed a low or a normal protein diet, while 128
times more amounts of glomerular membrane proteins were
used for the determination of this enzyme. Thus, the activity of
cyclooxygenase determined in this study may be mainly derived
from cyclooxygenase 1. However, negative staining does not
exclude completely the possibility that cyclooxygenase 2 is
expressed at the level undetected by the two antibodies used.
Recent evidence suggests that plasma and/or intrarenal renin-
angiotensin system has a major role in enhanced production of
glomerular eicosanoids seen in the setting of BUO or in the
course of feeding diets with greater protein content [5—7].
Indeed, angiotensin II is elevated shortly after the induction of
obstruction [181 and pretreatment with the ACE inhibitor,
enalaprilat, prior to obstruction blocks an increase in the
production of eicosanoids and an increase in the activities of
cyclooxygenase and membrane-bound PE-specific PLA2 ob-
served in glomeruli obtained from rats with BUO [6, 7].
Similarly, dietary protein enhances the activity of plasma renin
[9, 10] and the expression of renal renin mRNA [19, 201 in a
dose-dependent fashion. Blockade of the synthesis of endoge-
nous angiotensin II with the ACE inhibitor, enalapril, attenu-
ates an increase in the production of eicosanoids by glomeruli
isolated from high protein (40% casein)-fed rats to levels
comparable to that of glomeruli obtained from low protein
(8.5% casein)-fed rats [5]. Thus, it is suggested that dietary
protein restriction prevents a rise in glomerular eicosanoid
production occurring after the onset of BUO, possibly due to
suppression of the renin-angiotensin system.
Previous micropuncture studies [8] demonstrated a beneficial
effect of dietary protein restriction on the decrease in single
nephron function observed at 24 hours of BUO. There was a
significant amelioration of the fall of SNGFR and QA by 48%
and 54%, respectively, in BUO rats fed a low protein (6%
casein) diet for approximately four weeks compared to those
fed a high protein (40% casein) diet for the same period of time.
The potent vasoconstrictor TxA2 has been shown to alter renal
hemodynamics in the setting of BUO via an increase in renal
vascular resistance and a decrease in the ultrafiltration coeffi-
cient [8, 18, 21, 22]. Thus, the improved renal hemodynamics
observed in BUO rats fed a low protein diet may in part result
from inhibition of the action of glomerular TxA2 due to block-
ade of BUO-induced increases in the production of this vaso-
constrictor.
Dietary protein restriction slows the progression of renal
disease in experimental animals and humans [8—11]. The pro-
tective effect of dietary protein restriction on the progression of
renal disease may be due to the combined action of several
different mechanisms (inhibition of renal hypertrophy, immune-
cell activation and intraglomerular coagulation and decrease in
intraglomerular pressure and flow and serum lipid levels) [9, 10,
23]. In several types of renal disease increased glomerular TxA2
causes glomerular injury which is the common cause of pro-
gressive renal disease through intraglomerular hypertension
and coagulation [23, 24]. Inhibition of the increased production
of TxA2 with the thromboxane synthase inhibitor prevents
histologically the progression of glomerular injury [23, 24].
Thus, it is conceivable that the preventive effect of dietary
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protein restriction on the progression of renal disease may be in
part related to the protection of glomerular injury due to
inhibition of an increase in the production of glomerular TxA2.
Indeed, dietary protein restriction ameliorates increased pro-
duction of glomerijiar TxA2 in some of the other experimental
models of renal disease [5] as well as in ureteral obstruction.
In summary, novel aspects of this study are the findings that
dietary protein restriction normalizes the increased production
of glomerular PGE2, prostacyclin and TxA2 seen at 24 hours
after the onset of BUO by blocking the activation of PLA2 and
cyclooxygenase. Such effects of dietary protein restriction on
the increased production of glomerular eicosanoids, especially
TxA2 by BUO may be one of the beneficial effects of this
protein manipulation in preventing the decrement in GFR and
renal plasma flow that develops after the induction of BUO.
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